SCHEMBL6061237

SCHEMBL6061237

CCOP(=O)(OCC)C(Cc1cccc(OC)c1)c1cccnc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.44
TAAR1 Q96RJ0 2/20 0.42
ABCB1 P08183 1/20 0.41
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
HTR1A P08908 1/20 0.40
DRD2 P14416 1/20 0.40
MAPT P10636 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
TNIK Q9UKE5 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.39
GFER P55789 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6060960 0.81 PDE4D (0.43) ALDH1A1NPC1LMNASLC6A2SLC6A4
SCHEMBL6061529 0.78 PDE4D (0.40) ALDH1A1NPC1SLC6A2SLC6A4KMT2A
SCHEMBL6060881 0.78 GAA (0.43) ALDH1A1NPC1LMNAMAPTSLC6A2
SCHEMBL5662741 0.77 FDPS (0.42) ALDH1A1KMT2AHPGDTSHR
SCHEMBL5663447 0.74 FDPS (0.44) ALDH1A1NPC1LMNARAB9AKMT2A
SCHEMBL5663721 0.74 FDPS (0.39) ALDH1A1SLC6A2SLC6A4KMT2ATSHR
SCHEMBL6061007 0.72 POLB (0.49) KCNA5ALDH1A1NPC1LMNAMAPT
SCHEMBL6060950 0.72 POLB (0.37) KCNA5ALDH1A1NPC1LMNAMAPT
SCHEMBL7349979 0.72 TAAR1 (0.48) TAAR1ALDH1A1LMNAMAPTKMT2A
SCHEMBL9224803 0.71 POLB (0.43) KCNA5ALDH1A1NPC1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482953-A4 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES ILEX PRODUCTS INC (US) 2006-12-13 EP disclosed
US-20050124581-A1 Alpha-substituted heteroarylalkyl phosphonate derivatives PHAN HIEU T (CH) 2005-06-09 US disclosed
EP-1482953-A1 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES Ilex Products, Inc. (US) 2004-12-08 EP disclosed
WO-2003068240-A1 ALPHA-SUBSTITUTED HETEROARYLALKYL PHOSPHONATE DERIVATTIVES ILEX PRODUCTS, INC. (US) 2003-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124581-A1 Alpha-substituted heteroarylalkyl phosphonate derivatives APOB, APOL1, LDLR KCNA5 3121/4885TAAR1 1501/4885ABCB1 928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.